Trump, Donald L., MD

Dr. Donald L. Trump was appointed President and Chief Executive Officer of Roswell Park Cancer Institute (RPCI) on April 1, 2007. Since coming to RPCI in January 2002, Dr. Trump has served as Senior Vice President for Clinical Research; Chair, Department of Medicine; and Co-Principal Investigator of the Cancer Center Support Grant (CCSG) funded by the National Cancer Institute. In the fall of 2006, he was appointed Associate Institute Director.

 

As RPCI President & CEO and Principal Investigator of the CCSG, Dr. Trump has direct authority over day-to-day operations, philanthropic and operating budgets, capital improvements, research priorities and  clinical and scientific strategic planning for the Institute. He is responsible for establishing a culture of excellence throughout RPCI’s key mission areas: research, clinical care, education and cancer prevention.

 

In addition to his role as President and CEO, Dr. Trump continues his work as a researcher and clinician, leading the Institute’s active clinical research in vitamin D-based cancer prevention and treatment, caring for patients with prostate cancer and other urologic cancers. He also will continue as principal investigator or co-principal investigator on several grants funded by the National Cancer Institute and Department of Defense. He holds European and U.S. patents for the use of vitamin D and vitamin D analogues in combination with high-dose chemotherapy.

 

Dr. Trump earned his medical degree from The Johns Hopkins University School of Medicine, Baltimore, MD, in 1970. From 1970 to 1975, he completed an internship and residency training in Medicine and a fellowship in Oncology at The Johns Hopkins Hospital and served as Chief Resident in Internal Medicine at The Johns Hopkins Hospital. Dr. Trump is a Diplomate of the American Board of Internal Medicine, with Subspecialty Boards in Medical Oncology, and a Fellow of the American College of Physicians.

 

Dr. Trump is past Secretary/Treasurer of the American Society of Clinical Oncology, and is a member of many professional and scientific societies. He is a reviewer and/or member of the editorial board of prestigious journals, such as the New England Journal of Medicine, Journal of the National Cancer Institute, Cancer, Journal of Urologic Oncology, Clinical Cancer Research, Cure, Oncology, American Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Cancer Research, and Journal of Clinical Oncology. Dr. Trump has authored or co-authored more than 200 journal publications, book chapters and abstracts.